| Expression pattern: |
UP |
| Associated gene: |
TNFAIP3 |
| Associated microRNA: |
miR-138-5p |
| Biological function: |
Promotes HBV DNA replication and decreases/increases viral antigen expression (HBsAg, HBeAg) in HBV-infected HCC cells; knockdown inhibits HBV replication and expression. |
| Molecular mechanism: |
Acts as a ceRNA/miRNA sponge for miR-138-5p, thereby up-regulating TNFAIP3 and promoting HBV replication and expression. |
| Biological pathway or process: |
viral replication (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; Western Blot; ELISA |
| Clinical significance: |
Potential biomarker/therapeutic target for HBV-related HCC treatment. |
| Description: |
circ-ATP5H (hsa_circ_0006942) is up-regulated in HBV-positive HCC tissues and HBV-producing HCC cells. Functionally, circ-ATP5H promotes HBV DNA replication and viral antigen (HBsAg/HBeAg) production by sponging miR-138-5p to up-regulate TNFAIP3, forming a circ-ATP5H/miR-138-5p/TNFAIP3 ceRNA axis. |
| Confidence score: |
0.6369 |